{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:30:38Z","timestamp":1782855038635,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A strong dose-volume relationship exists between the amount of small bowel receiving low- to intermediate-doses of radiation and the rates of acute, severe gastrointestinal toxicity, principally diarrhea. There is considerable interest in the application of highly conformal treatment approaches, such as intensity-modulated radiation therapy (IMRT), to reduce dose to adjacent organs-at-risk in the treatment of carcinoma of the rectum. Therefore, we performed a comprehensive dosimetric evaluation of IMRT compared to 3-dimensional conformal radiation therapy (3DCRT) in standard, preoperative treatment for rectal cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using RTOG consensus anorectal contouring guidelines, treatment volumes were generated for ten patients treated preoperatively at our institution for rectal carcinoma, with IMRT plans compared to plans derived from classic anatomic landmarks, as well as 3DCRT plans treating the RTOG consensus volume. The patients were all T3, were node-negative (N = 1) or node-positive (N = 9), and were planned to a total dose of 45-Gy. Pairwise comparisons were made between IMRT and 3DCRT plans with respect to dose-volume histogram parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>IMRT plans had superior PTV coverage, dose homogeneity, and conformality in treatment of the gross disease and at-risk nodal volume, in comparison to 3DCRT. Additionally, in comparison to the 3DCRT plans, IMRT achieved a concomitant reduction in doses to the bowel (small bowel mean dose: 18.6-Gy IMRT versus 25.2-Gy 3DCRT; p = 0.005), bladder (V<jats:sub>40Gy<\/jats:sub>: 56.8% IMRT versus 75.4% 3DCRT; p = 0.005), pelvic bones (V<jats:sub>40Gy<\/jats:sub>: 47.0% IMRT versus 56.9% 3DCRT; p = 0.005), and femoral heads (V<jats:sub>40Gy<\/jats:sub>: 3.4% IMRT versus 9.1% 3DCRT; p = 0.005), with an improvement in absolute volumes of small bowel receiving dose levels known to induce clinically-relevant acute toxicity (small bowel V<jats:sub>15Gy<\/jats:sub>: 138-cc IMRT versus 157-cc 3DCRT; p = 0.005). We found that the IMRT treatment volumes were typically larger than that covered by classic bony landmark-derived fields, without incurring penalty with respect to adjacent organs-at-risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>For rectal carcinoma, IMRT, compared to 3DCRT, yielded plans superior with respect to target coverage, homogeneity, and conformality, while lowering dose to adjacent organs-at-risk. This is achieved despite treating larger volumes, raising the possibility of a clinically-relevant improvement in the therapeutic ratio through the use of IMRT with a belly-board apparatus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-6-63","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T18:49:56Z","timestamp":1307558996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma"],"prefix":"10.1186","volume":"6","author":[{"given":"Henry","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina M","family":"Briere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Beddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E","family":"Delclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"380_CR1","doi-asserted-by":"crossref","unstructured":"Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials Lancet 2001, 358: 1291-1304.","DOI":"10.1016\/S0140-6736(01)06409-1"},{"key":"380_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1056\/NEJM198611133152014","volume":"315","author":"HO Douglass Jr","year":"1986","unstructured":"Douglass HO Jr, Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, Stablein DM, Bruckner HW: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986, 315: 1294-1295.","journal-title":"N Engl J Med"},{"key":"380_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199103143241101","volume":"324","author":"JE Krook","year":"1991","unstructured":"Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, et al.: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991, 324: 709-715. 10.1056\/NEJM199103143241101","journal-title":"N Engl J Med"},{"key":"380_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351: 1731-1740. 10.1056\/NEJMoa040694","journal-title":"N Engl J Med"},{"key":"380_CR5","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009, 27: 5124-5130. 10.1200\/JCO.2009.22.0467","journal-title":"J Clin Oncol"},{"key":"380_CR6","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Braendengen","year":"2008","unstructured":"Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Pahlman L, Wiig JN, Bystrom P, Bujko K, Glimelius B: Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008, 26: 3687-3694. 10.1200\/JCO.2007.15.3858","journal-title":"J Clin Oncol"},{"key":"380_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","volume":"52","author":"KL Baglan","year":"2002","unstructured":"Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM: The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002, 52: 176-183. 10.1016\/S0360-3016(01)01820-X","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijrobp.2006.05.005","volume":"66","author":"LM Tho","year":"2006","unstructured":"Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, McDonald AC: Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006, 66: 505-513. 10.1016\/j.ijrobp.2006.05.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","volume":"70","author":"JM Robertson","year":"2008","unstructured":"Robertson JM, Lockman D, Yan D, Wallace M: The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70: 413-418. 10.1016\/j.ijrobp.2007.06.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR10","doi-asserted-by":"crossref","unstructured":"Robertson JM, Sohn M, Yan D: Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model. Int J Radiat Oncol Biol Phys 77: 66-72.","DOI":"10.1016\/j.ijrobp.2009.04.048"},{"key":"380_CR11","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ijrobp.2006.10.020","volume":"67","author":"R Fietkau","year":"2007","unstructured":"Fietkau R, Rodel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, et al.: Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO\/ARO\/AIO-94. Int J Radiat Oncol Biol Phys 2007, 67: 1008-1019. 10.1016\/j.ijrobp.2006.10.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0360-3016(85)90255-X","volume":"11","author":"LL Gunderson","year":"1985","unstructured":"Gunderson LL, Russell AH, Llewellyn HJ, Doppke KP, Tepper JE: Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 1985, 11: 1379-1393. 10.1016\/0360-3016(85)90255-X","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","volume":"52","author":"AJ Mundt","year":"2002","unstructured":"Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC: Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52: 1330-1337. 10.1016\/S0360-3016(01)02785-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijrobp.2005.05.052","volume":"63","author":"YJ Chen","year":"2005","unstructured":"Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY: Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal\/femoral nodes. Int J Radiat Oncol Biol Phys 2005, 63: 274-281. 10.1016\/j.ijrobp.2005.05.052","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-2-41","volume":"2","author":"C Menkarios","year":"2007","unstructured":"Menkarios C, Azria D, Laliberte B, Moscardo CL, Gourgou S, Lemanski C, Dubois JB, Ailleres N, Fenoglietto P: Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2007, 2: 41. 10.1186\/1748-717X-2-41","journal-title":"Radiat Oncol"},{"key":"380_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ijrobp.2005.12.056","volume":"65","author":"MT Guerrero Urbano","year":"2006","unstructured":"Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, Nutting CM, Dearnaley DP, Tait DM: Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006, 65: 907-916. 10.1016\/j.ijrobp.2005.12.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR17","doi-asserted-by":"crossref","unstructured":"Arbea L, Ramos LI, Martinez-Monge R, Moreno M, Aristu J: Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 5: 17.","DOI":"10.1186\/1748-717X-5-17"},{"key":"380_CR18","unstructured":"A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Moldulated Radiation Therapy (IMRT) in Combination with Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer[http:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0822]"},{"key":"380_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, et al.: Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009, 74: 824-830. 10.1016\/j.ijrobp.2008.08.070","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR20","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/0360-3016(86)90279-8","volume":"12","author":"MJ Gallagher","year":"1986","unstructured":"Gallagher MJ, Brereton HD, Rostock RA, Zero JM, Zekoski DA, Poyss LF, Richter MP, Kligerman MM: A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986, 12: 1565-1573. 10.1016\/0360-3016(86)90279-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"380_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","volume":"65","author":"EJ Hall","year":"2006","unstructured":"Hall EJ: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65: 1-7. 10.1016\/j.ijrobp.2006.01.027","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-6-63.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T14:09:29Z","timestamp":1630505369000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-6-63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-6-63","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]},"assertion":[{"value":"30 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}